TK
Takeda Pharmaceutical Company Limited
TKPHF · OTC
$36.20 +2.43% (+$0.86)
1M +3.90%
Market Cap ¥8.68T
P/E Ratio 48.07x
Div. Yield 3.69%
ROE 2.40%
Bulios Fair Price
$53.37
47.5% upside
Trenutna cena
$36.2
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica TKPHF trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Moderate
5/9Valuation
71 /100
Cheap EV/EBITDA 10.02x
P/S 1.88x
P/B 1.15x
Growth
45 /100
Stable Rev. growth 4.03%
FCF growth 30.74%
Book val. growth 7.18%
Profitability
66 /100
Moderate Net margin 3.90%
Op. margin 10.98%
FCF margin 15.14%
Quality
12 /100
Poor ROE 2.40%
ROA 1.15%
Asset turnover 0.30x
Debt
46 /100
Moderate Current ratio 1.14x
Int. coverage 2.04x
Net debt/EBITDA 3.41x
Stability
49 /100
Moderate Rev. volatility 4.51%
EPS volatility 70.07%
Profitable years 6
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o TKPHF
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Julie So-Young Kim
Employees
47,029
Headquarters
Tokyo
Prihajajoči dogodki
29 SEP.
Ex-Dividend
Ex-dividend date
29 SEP.
Dividend Payment
Datum plačila
29 OKT.
Earnings
Upcoming earnings report
30 MAR.
Ex-Dividend
Ex-dividend date
30 MAR.
Dividend Payment
Datum plačila